SAMRAT PHARMACHEM
Back to Cashflow Statement
|
SAMRAT PHARMACHEM Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-9.62 Cr | ₹-2.19 Cr | ₹-2.84 Cr | ₹14 Cr | ₹-0.02 Cr |
What is the latest Net Cash Inflow / Outflow ratio of SAMRAT PHARMACHEM ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-9.62 Cr |
| Mar2024 | ₹-2.19 Cr |
| Mar2023 | ₹-2.84 Cr |
| Mar2022 | ₹14 Cr |
| Mar2021 | ₹-0.02 Cr |
How is Net Cash Inflow / Outflow of SAMRAT PHARMACHEM Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-9.62 Cr | Negative | |
| Mar2024 | ₹-2.19 Cr | Negative | |
| Mar2023 | ₹-2.84 Cr | Negative | |
| Mar2022 | ₹14 Cr | Positive | |
| Mar2021 | ₹-0.02 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of SAMRAT PHARMACHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAMRAT PHARMACHEM | ₹69.7 Cr | 5.2% | 6.3% | -33.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,937.0 Cr | -1.4% | -7.2% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,359.0 Cr | 5.7% | 0.3% | 14.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,431.0 Cr | 1.5% | -6.5% | 28.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,114.0 Cr | 0.7% | -7.4% | 9.9% | Stock Analytics | |
| CIPLA | ₹100,028.0 Cr | 0.5% | -7.1% | -14.4% | Stock Analytics | |
SAMRAT PHARMACHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAMRAT PHARMACHEM | 5.2% |
6.3% |
-33.1% |
| SENSEX | 0.6% |
1.5% |
6.6% |
You may also like the below Video Courses